{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:05:11Z","timestamp":1786982711060,"version":"build-2736575974"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T00:00:00Z","timestamp":1715299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T00:00:00Z","timestamp":1715299200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012330","name":"Okayama University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012330","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      We aimed to improve the prognosis, treatment, and management of\n                      <jats:italic>Staphylococcus aureus<\/jats:italic>\n                      bacteremia (SAB) by evaluating the association between adherence to quality indicators (QIs) and clinical outcomes in patients with their clinical outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively collected clinical and microbiological data on hospitalized patients with SAB from 14 hospitals (three with\u2009&gt; \u2009600, two with 401\u2013600, five with 201\u2013400, and four with\u2009\u2264\u2009200 beds) in Japan from January to December 2022. The SAB management quality was evaluated using the SAB-QI score (ranging from 0 to 13 points), which consists of 13 QIs (grouped into five categories) based on previous literature.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 4,448 positive blood culture episodes, 289 patients with SAB (6.5%) were enrolled. The SAB-QI scores ranged from 3 to 13, with a median score of 9 points. The SAB-QI score was highest in middle-sized hospitals with 401\u2013600 beds. Adherence to each of the four QI categories (blood culture, echocardiography, source control, and antibiotic treatment) was significantly higher in survived cases than in fatal cases. Kaplan\u2013Meier curves with log-rank tests demonstrated that higher adherence to SAB-QIs indicated a better prognosis. Logistic regression analysis revealed that age, methicillin resistance, multiple comorbidities (\u2265\u00a02), and low SAB-QI score were significantly associated with 30-day mortality in patients with SAB.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our study highlights that greater adherence to the SAB-QIs correlates with improved patient outcomes. Management of patients with SAB should follow these recommended indicators to maintain the quality of care, especially for patients with poor prognosticators.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s15010-024-02284-z","type":"journal-article","created":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T07:01:56Z","timestamp":1715324516000},"page":"1527-1538","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Adherence to and clinical utility of \u201cquality indicators\u201d for Staphylococcus aureus bacteremia: a retrospective, multicenter study"],"prefix":"10.1007","volume":"52","author":[{"given":"Shinnosuke","family":"Fukushima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideharu","family":"Hagiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Kuninaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuto","family":"Haruki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruto","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Iwamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayo","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kota","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihisa","family":"Hanayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Miyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keigo","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumio","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,10]]},"reference":[{"key":"2284_CR1","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1128\/CMR.00134-14","volume":"28","author":"SYC Tong","year":"2015","unstructured":"Tong SYC, Davis JS, Eichenberger E, Holland TL, Fowler VG Jr. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 2015;28:603\u201361.","journal-title":"Clin Microbiol Rev"},{"key":"2284_CR2","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1128\/CMR.05022-11","volume":"25","author":"SJ van Hal","year":"2012","unstructured":"van Hal SJ, Jensen SO, Vaska VL, Espedido BA, Paterson DL, Gosbell IB. Predictors of mortality in Staphylococcus aureus Bacteremia. Clin Microbiol Rev. 2012;25:362\u201386.","journal-title":"Clin Microbiol Rev"},{"key":"2284_CR3","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1001\/jama.2014.9743","volume":"312","author":"TL Holland","year":"2014","unstructured":"Holland TL, Arnold C, Fowler VG Jr. Clinical management of Staphylococcus aureus bacteremia: a review. JAMA. 2014;312:1330\u201341.","journal-title":"JAMA"},{"key":"2284_CR4","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1093\/cid\/ciz498","volume":"70","author":"ED Austin","year":"2020","unstructured":"Austin ED, Sullivan SS, Macesic N, Mehta M, Miko BA, Nematollahi S, et al. Reduced mortality of Staphylococcus aureus bacteremia in a retrospective cohort study of 2139 patients: 2007\u20132015. Clin Infect Dis. 2020;70:1666\u201374.","journal-title":"Clin Infect Dis"},{"key":"2284_CR5","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1093\/cid\/ciad500","volume":"77","author":"DJ Minter","year":"2023","unstructured":"Minter DJ, Appa A, Chambers HF, Doernberg SB. Contemporary management of Staphylococcus aureus bacteremia-controversies in clinical practice. Clin Infect Dis. 2023;77:e57-68.","journal-title":"Clin Infect Dis"},{"key":"2284_CR6","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1128\/AAC.01021-12","volume":"57","author":"YP Chong","year":"2013","unstructured":"Chong YP, Moon SM, Bang K-M, Park HJ, Park S-Y, Kim M-N, et al. Treatment duration for uncomplicated Staphylococcus aureus bacteremia to prevent relapse: analysis of a prospective observational cohort study. Antimicrob Agents Chemother. 2013;57:1150\u20136.","journal-title":"Antimicrob Agents Chemother"},{"key":"2284_CR7","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.cmi.2019.07.019","volume":"26","author":"M Abbas","year":"2020","unstructured":"Abbas M, Rossel A, de Kraker MEA, von Dach E, Marti C, Emonet S, et al. Association between treatment duration and mortality or relapse in adult patients with Staphylococcus aureus bacteraemia: a retrospective cohort study. Clin Microbiol Infect. 2020;26:626\u201331.","journal-title":"Clin Microbiol Infect"},{"key":"2284_CR8","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/S1473-3099(20)30447-3","volume":"20","author":"R Kuehl","year":"2020","unstructured":"Kuehl R, Morata L, Boeing C, Subirana I, Seifert H, Rieg S, et al. Defining persistent Staphylococcus aureus bacteraemia: secondary analysis of a prospective cohort study. Lancet Infect Dis. 2020;20:1409\u201317.","journal-title":"Lancet Infect Dis"},{"key":"2284_CR9","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/cid\/ciz257","volume":"70","author":"E Minejima","year":"2020","unstructured":"Minejima E, Mai N, Bui N, Mert M, Mack WJ, She RC, et al. Defining the breakpoint duration of Staphylococcus aureus bacteremia predictive of poor outcomes. Clin Infect Dis. 2020;70:566\u201373.","journal-title":"Clin Infect Dis"},{"key":"2284_CR10","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.1093\/jac\/dkz342","volume":"74","author":"J Ten Oever","year":"2019","unstructured":"Ten Oever J, Jansen JL, van der Vaart TW, Schouten JA, Hulscher MEJL, Verbon A. Development of quality indicators for the management of Staphylococcus aureus bacteraemia. J Antimicrob Chemother. 2019;74:3344\u201351.","journal-title":"J Antimicrob Chemother"},{"key":"2284_CR11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13054-019-2377-x","volume":"23","author":"JA Huijben","year":"2019","unstructured":"Huijben JA, Wiegers EJA, de Keizer NF, Maas AIR, Menon D, Ercole A, et al. Development of a quality indicator set to measure and improve quality of ICU care for patients with traumatic brain injury. Crit Care. 2019;23:95.","journal-title":"Crit Care"},{"key":"2284_CR12","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.wneu.2017.03.111","volume":"104","author":"S Schipmann","year":"2017","unstructured":"Schipmann S, Schwake M, Suero Molina E, Roeder N, Steudel W-I, Warneke N, et al. Quality indicators in cranial neurosurgery: which are presently substantiated? A systematic review. World Neurosurg. 2017;104:104\u201312.","journal-title":"World Neurosurg"},{"key":"2284_CR13","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/cid\/cit499","volume":"57","author":"LE L\u00f3pez-Cort\u00e9s","year":"2013","unstructured":"L\u00f3pez-Cort\u00e9s LE, Del Toro MD, G\u00e1lvez-Acebal J, Bereciartua-Bastarrica E, Fari\u00f1as MC, Sanz-Franco M, et al. Impact of an evidence-based bundle intervention in the quality-of-care management and outcome of Staphylococcus aureus bacteremia. Clin Infect Dis. 2013;57:1225\u201333.","journal-title":"Clin Infect Dis"},{"key":"2284_CR14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s15010-016-0946-3","volume":"45","author":"M Nagao","year":"2017","unstructured":"Nagao M, Yamamoto M, Matsumura Y, Yokota I, Takakura S, Teramukai S, et al. Complete adherence to evidence-based quality-of-care indicators for Staphylococcus aureus bacteremia resulted in better prognosis. Infection. 2017;45:83\u201391.","journal-title":"Infection"},{"key":"2284_CR15","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1093\/cid\/civ120","volume":"60","author":"AD Bai","year":"2015","unstructured":"Bai AD, Showler A, Burry L, Steinberg M, Ricciuto DR, Fernandes T, et al. Impact of infectious disease consultation on quality of care, mortality, and length of stay in Staphylococcus aureus bacteremia: results from a large multicenter cohort study. Clin Infect Dis. 2015;60:1451\u201361.","journal-title":"Clin Infect Dis"},{"key":"2284_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/bmjquality.u201154.w908","author":"C Meyer","year":"2013","unstructured":"Meyer C, Pett E. Improving the management of Staphylococcus aureus bacteraemia, including MRSA. BMJ Qual Improv Rep. 2013;2:u201154.w908.","journal-title":"BMJ Qual Improv Rep"},{"key":"2284_CR17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.amjmed.2015.09.016","volume":"129","author":"J Townsend","year":"2016","unstructured":"Townsend J, Pelletier J, Peterson G, Matulevicius S, Sreeramoju P. Quality improvement of Staphylococcus aureus bacteremia management and predictors of relapse-free survival. Am J Med. 2016;129:195\u2013203.","journal-title":"Am J Med"},{"key":"2284_CR18","doi-asserted-by":"crossref","first-page":"5682","DOI":"10.1128\/AAC.00439-16","volume":"60","author":"RB Turner","year":"2016","unstructured":"Turner RB, Valcarlos E, Won R, Chang E, Schwartz J. Impact of infectious diseases consultation on clinical outcomes of patients with Staphylococcus aureus bacteremia in a community health system. Antimicrob Agents Chemother. 2016;60:5682\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"2284_CR19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jinf.2015.09.037","volume":"72","author":"M Vogel","year":"2016","unstructured":"Vogel M, Schmitz RPH, Hagel S, Pletz MW, Gagelmann N, Scherag A, et al. Infectious disease consultation for Staphylococcus aureus bacteremia\u2014a systematic review and meta-analysis. J Infect. 2016;72:19\u201328.","journal-title":"J Infect"},{"key":"2284_CR20","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1086\/377540","volume":"37","author":"S-H Kim","year":"2003","unstructured":"Kim S-H, Park W-B, Lee K-D, Kang C-I, Kim H-B, Oh M-D, et al. Outcome of Staphylococcus aureus bacteremia in patients with eradicable foci versus noneradicable foci. Clin Infect Dis. 2003;37:794\u20139.","journal-title":"Clin Infect Dis"},{"key":"2284_CR21","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/cid\/cix287","volume":"65","author":"JS McDanel","year":"2017","unstructured":"McDanel JS, Roghmann M-C, Perencevich EN, Ohl ME, Goto M, Livorsi DJ, et al. Comparative effectiveness of cefazolin versus nafcillin or oxacillin for treatment of methicillin-susceptible Staphylococcus aureus infections complicated by bacteremia: a nationwide cohort study. Clin Infect Dis. 2017;65:100\u20136.","journal-title":"Clin Infect Dis"},{"key":"2284_CR22","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1469-0691.2005.01359.x","volume":"12","author":"C Kaech","year":"2006","unstructured":"Kaech C, Elzi L, Sendi P, Frei R, Laifer G, Bassetti S, et al. Course and outcome of Staphylococcus aureus bacteraemia: a retrospective analysis of 308 episodes in a Swiss tertiary-care centre. Clin Microbiol Infect. 2006;12:345\u201352.","journal-title":"Clin Microbiol Infect"},{"key":"2284_CR23","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics. Bone Marrow Transplant. 2013;48:452\u20138.","journal-title":"Bone Marrow Transplant"},{"key":"2284_CR24","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1017\/S0950268816000613","volume":"144","author":"KB Laupland","year":"2016","unstructured":"Laupland KB, Pasquill K, Parfitt EC, Naidu P, Steele L. Burden of community-onset bloodstream infections, Western Interior, British Columbia Canada. Epidemiol Infect. 2016;144:2440\u20136.","journal-title":"Epidemiol Infect"},{"key":"2284_CR25","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/1469-0691.12083","volume":"19","author":"M Nagao","year":"2013","unstructured":"Nagao M. A multicentre analysis of epidemiology of the nosocomial bloodstream infections in Japanese university hospitals. Clin Microbiol Infect. 2013;19:852\u20138.","journal-title":"Clin Microbiol Infect"},{"key":"2284_CR26","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/ams2.316","volume":"5","author":"K Miyamoto","year":"2018","unstructured":"Miyamoto K, Kato S, Kitayama J, Okawa J, Okamoto A, Kamei J, et al. Adherence rate of quality-of-care indicators for Staphylococcus aureus bacteremia is extremely low in Japanese emergency and critical care departments: a multicenter retrospective observational study. Acute Med Surg. 2018;5:140\u20135.","journal-title":"Acute Med Surg"},{"key":"2284_CR27","doi-asserted-by":"crossref","first-page":"18033","DOI":"10.1038\/nrdp.2018.33","volume":"4","author":"AS Lee","year":"2018","unstructured":"Lee AS, de Lencastre H, Garau J, Kluytmans J, Malhotra-Kumar S, Peschel A, et al. Methicillin-resistant Staphylococcus aureus. Nat Rev Dis Primers. 2018;4:18033.","journal-title":"Nat Rev Dis Primers"},{"key":"2284_CR28","first-page":"255","volume":"77","author":"S Fukushima","year":"2023","unstructured":"Fukushima S, Hagiya H, Uda K, Gotoh K, Otsuka F. Current prevalence of antimicrobial resistance in Okayama from a national database between 2018 and 2021. Acta Med Okayama. 2023;77:255\u201362.","journal-title":"Acta Med Okayama"},{"key":"2284_CR29","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.cmi.2022.10.019","volume":"29","author":"F Escrihuela-Vidal","year":"2023","unstructured":"Escrihuela-Vidal F, Kaasch AJ, Von Cube M, Rieg S, Kern WV, Seifert H, et al. Impact of adherence to individual quality-of-care indicators on the prognosis of bloodstream infection due to Staphylococcus aureus: a prospective observational multicentre cohort. Clin Microbiol Infect. 2023;29:498\u2013505.","journal-title":"Clin Microbiol Infect"},{"key":"2284_CR30","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ijid.2020.11.199","volume":"103","author":"Y Hadano","year":"2021","unstructured":"Hadano Y, Kakuma T, Matsumoto T, Ishibashi K, Isoda M, Yasunaga H. Reduction of 30-day death rates from Staphylococcus aureus bacteremia by mandatory infectious diseases consultation: comparative study interventions with and without an infectious disease specialist. Int J Infect Dis. 2021;103:308\u201315.","journal-title":"Int J Infect Dis"},{"key":"2284_CR31","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/AOG.0000000000002164","volume":"130","author":"JD Wright","year":"2017","unstructured":"Wright JD, Chen L, Hou JY, Burke WM, Tergas AI, Ananth CV, et al. Association of hospital volume and quality of care with survival for ovarian cancer. Obstet Gynecol. 2017;130:545\u201353.","journal-title":"Obstet Gynecol"},{"key":"2284_CR32","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1007\/s00068-022-02205-5","volume":"49","author":"W\u00fcrdemann FS, van Zwet EW, Krijnen P, Hegeman JH, Schipper IB, Dutch Hip Fracture Audit Group","year":"2023","unstructured":"W\u00fcrdemann FS, van Zwet EW, Krijnen P, Hegeman JH, Schipper IB, Dutch Hip Fracture Audit Group. Is hospital volume related to quality of hip fracture care? Analysis of 43,538 patients and 68 hospitals from the Dutch Hip Fracture Audit. Eur J Trauma Emerg Surg. 2023;49:1525\u201334.","journal-title":"Eur J Trauma Emerg Surg"},{"key":"2284_CR33","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1056\/NEJMsa0907130","volume":"362","author":"JS Ross","year":"2010","unstructured":"Ross JS, Normand S-LT, Wang Y, Ko DT, Chen J, Drye EE, et al. Hospital volume and 30-day mortality for three common medical conditions. N Engl J Med. 2010;362:1110\u20138.","journal-title":"N Engl J Med"},{"key":"2284_CR34","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1017\/ice.2019.136","volume":"40","author":"JE Sherbuk","year":"2019","unstructured":"Sherbuk JE, McManus D, Topal JE, Malinis M. Improved mortality in Staphylococcus aureus bacteremia with the involvement of antimicrobial stewardship team and infectious disease consultation. Infect Control Hosp Epidemiol. 2019;40:932\u20135.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2284_CR35","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41579-018-0147-4","volume":"17","author":"NA Turner","year":"2019","unstructured":"Turner NA, Sharma-Kuinkel BK, Maskarinec SA, Eichenberger EM, Shah PP, Carugati M, et al. Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research. Nat Rev Microbiol. 2019;17:203\u201318.","journal-title":"Nat Rev Microbiol"},{"key":"2284_CR36","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/MD.0b013e3181f1851e","volume":"89","author":"S-Y Chen","year":"2010","unstructured":"Chen S-Y, Wang J-T, Chen TH-H, Lai M-S, Chie W-C, Chien K-L, et al. Impact of traditional hospital strain of methicillin-resistant Staphylococcus aureus (MRSA) and community strain of MRSA on mortality in patients with community-onset S aureus bacteremia. Medicine. 2010;89:285\u201394.","journal-title":"Medicine"},{"key":"2284_CR37","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","volume":"52","author":"C Liu","year":"2011","unstructured":"Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52:e18\u201355.","journal-title":"Clin Infect Dis"},{"key":"2284_CR38","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/s13063-019-3357-9","volume":"20","author":"L Thorlacius-Ussing","year":"2019","unstructured":"Thorlacius-Ussing L, Andersen C\u00d8, Frimodt-M\u00f8ller N, Knudsen IJD, Lundgren J, Benfield TL. Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia (SAB7): study protocol for a randomized controlled trial. Trials. 2019;20:250.","journal-title":"Trials"},{"key":"2284_CR39","doi-asserted-by":"crossref","first-page":"e068295","DOI":"10.1136\/bmjopen-2022-068295","volume":"13","author":"D Buis","year":"2023","unstructured":"Buis D, van Werkhoven CH, van Agtmael MA, Bax HI, Berrevoets M, de Boer M, et al. Safe shortening of antibiotic treatment duration for complicated Staphylococcus aureus bacteraemia (SAFE trial): protocol for a randomised, controlled, open-label, non-inferiority trial comparing 4 and 6 weeks of antibiotic treatment. BMJ Open. 2023;13:e068295.","journal-title":"BMJ Open"},{"key":"2284_CR40","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S1473-3099(23)00756-9","volume":"24","author":"AJ Kaasch","year":"2024","unstructured":"Kaasch AJ, L\u00f3pez-Cort\u00e9s LE, Rodr\u00edguez-Ba\u00f1o J, Cisneros JM, Dolores Navarro M, F\u00e4tkenheuer G, et al. Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trial. Lancet Infect Dis. 2024;24:523\u201334.","journal-title":"Lancet Infect Dis"},{"key":"2284_CR41","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.amjmed.2022.09.017","volume":"136","author":"JC Lam","year":"2023","unstructured":"Lam JC, Stokes W. The golden grapes of wrath\u2014Staphylococcus aureus bacteremia: a clinical review. Am J Med. 2023;136:19\u201326.","journal-title":"Am J Med"},{"key":"2284_CR42","doi-asserted-by":"crossref","first-page":"e0291677","DOI":"10.1371\/journal.pone.0291677","volume":"18","author":"H Hagiya","year":"2023","unstructured":"Hagiya H. Shortage and unequal distribution of infectious disease specialists in Japan: how can we refine the current situation? PLoS ONE. 2023;18:e0291677.","journal-title":"PLoS ONE"},{"issue":"4","key":"2284_CR43","doi-asserted-by":"crossref","first-page":"ofz098","DOI":"10.1093\/ofid\/ofz098","volume":"6","author":"S Remtulla","year":"2019","unstructured":"Remtulla S, Zurek K, Cervera C, Hernandez C, Lee M-C, Hoang HL. Impact of an unsolicited, standardized form-based antimicrobial stewardship intervention to improve guideline adherence in the management of Staphylococcus aureus bacteremia. Open Forum Infect Dis. 2019;6:ofz098.","journal-title":"Open Forum Infect Dis"},{"key":"2284_CR44","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/clind\/24.4.584","volume":"24","author":"MP Weinstein","year":"1997","unstructured":"Weinstein MP, Towns ML, Quartey SM, Mirrett S, Reimer LG, Parmigiani G, et al. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis. 1997;24:584\u2013602.","journal-title":"Clin Infect Dis"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-024-02284-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-024-02284-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-024-02284-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T14:51:34Z","timestamp":1722351094000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-024-02284-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,10]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["2284"],"URL":"https:\/\/doi.org\/10.1007\/s15010-024-02284-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3977124\/v1","asserted-by":"object"}]},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,10]]},"assertion":[{"value":"22 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval was obtained from the Institutional Review Board of Okayama University Hospital (No. 2302\u2013027).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The requirement for informed consent was waived because this was a retrospective analysis of routinely collected anonymous data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}